H-1B sponsorship profile: Intra-Cellular Therapies, Inc. Across U.S. Department of Labor LCA disclosures, Intra-Cellular Therapies, Inc filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2024 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Intra-Cellular Therapies, Inc’s H-1B petitions range from $165,860 at the low end to $179,296 at the high end, with a petition-weighted average of $172,578. That range reflects the mix of occupations the company sponsors, led by Director, Clinical Quality Assurance (1 petitions at $179,296 avg), followed by Associate Director, Statistical Programming. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Intra-Cellular Therapies, Inc is headquartered in New York, NY under NAICS code 325412, and places H-1B workers across 2 states, most heavily in NJ, NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Intra-Cellular Therapies, Inc ranks. By H-1B petition volume, Intra-Cellular Therapies, Inc is #48,558 of 119,880 employers nationally and #5,366 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.